Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

58.90 -0.18 (-0.30%)
Official Closing Price Updated: 7:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bristol-Myers Squibb

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
42 43 Next >
The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Bristol Myers Squibb Enters Into $5 Billion Aggregate Accelerated Share Repurchase Agreements
From Bristol Myers Squibb
Via Business Wire
2 Natural-Killer Cell Therapy Oncology Companies Investors Should Watch
Natural-killer cell therapy is one of the most recent paradigms in cancer treatment, and two prominent companies working on this new technology are Fate Therapeutics Inc (NASDAQ: FATE) and Century... 
Via Benzinga
Bristol Myers Squibb Awards Nearly $8 Million in New Health Equity Grants to Improve Access to Care for Medically Underserved Patients in U.S.
From Bristol Myers Squibb
Via Business Wire
Bristol Myers Q4 Revenue, FY22 Sales Outlook Lag Consensus
Bristol Myers Squibb & Co (NYSE: BMY) has posted  
Via Benzinga
Looking At Bristol-Myers Squibb's Recent Whale Trades
A whale with a lot of money to spend has taken a noticeably bullish stance on Bristol-Myers Squibb. Looking at options history for Bristol-Myers Squibb (NYSE:BMY) we detected 17 strange trades. 
Via Benzinga
Stock Market Rally Volatile; Google, Facebook, Amazon, Snap Are Earnings Movers: Weekly Review
The major indexes slashed weekly gains after Monday's follow-through day. 
Via Investor's Business Daily
5 Biotech Stocks to Buy to Benefit From Biden’s New Cancer Cabinet
Joe Biden is redoubling his efforts to fight cancer with a new "cancer cabinet." Here are the biotech stocks to buy that can benefit. 
Via InvestorPlace
Bristol Myers Squibb (BMY) Q4 Earnings Meet Estimates
Bristol Myers Squibb came out with quarterly earnings of $1.83 per share. 
Via Talk Markets
EMA's Advisory Committee Recommends Approval Of Bristol-Myers' Breyanzi In Lymphoma
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP)  
Via Benzinga
Bristol Myers Ekes Out Earnings Beat As Cancer Drugs Spur Growth
The best growth during the quarter came from a blood thinner, an anemia treatment and cancer drugs. 
Via Investor's Business Daily
ADDING and REPLACING Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021
From Bristol Myers Squibb
Via Business Wire
Bristol-Myers Squibb: Q4 Earnings Insights
  Bristol-Myers Squibb (NYSE:BMY) reported its Q4 earnings results on Friday, February 4, 2022 at 06:59 AM. Here's what investors need to know about the announcement. 
Via Benzinga
The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021
From Bristol Myers Squibb
Via Business Wire
5 Stocks To Watch For February 4, 2022
Some of the stocks that may grab inve3stor focus today are: Wall Street expects Bristol-Myers Squibb Company (NYSE: BMY) to report quarterly earnings at $1.80 per share on revenue of $12.08 billion... 
Via Benzinga
Earnings Scheduled For February 4, 2022
Companies Reporting Before The Bell • Brookfield Business (NYSE:BBU) is estimated to report earnings for its fourth quarter. 
Via Benzinga
Facebook FB plunges but Amazon AMZN surges: Earnings and Your Updated Price Levels
It seems like yesterday we were discussing the surge in Alphabet shares, and today we're focusing on big moves - currently in opposite directions - of Facebook and Amazon, all major market cap... 
Via Talk Markets
Earnings Outlook For Bristol-Myers Squibb
Bristol-Myers Squibb (NYSE:BMY) is set to give its latest quarterly earnings report on Friday, 2022-02-04. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
Psoriasis Drug Providers Looking Over Shoulders At Upcoming Competitor?
Photo by Diana Polekhina on Unsplash 
Via Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Amendments To Canada's Special Access Program (SAP) Allows Access To Restricted Psychedelic Drugs. How Will This Affect The Industry?
Photo by Bob Coyne on Unsplash 
Via Benzinga
5 Things To Expect This Week
While the "January effect" was rather disappointing, February kicks off with an important week ahead for many types of investors. 
Via InvestorPlace
Groundbreaking Clinical Trials Accelerating New Treatment Options for Pancreatic Cancer
Palm Beach, FL – February 2, 2022 – FinancialNewsMedia.com News Commentary – In the battle against pancreatic cancer, new and innovative clinical trials have become extremely critical. These trials... 
Via FinancialNewsMedia
Small Cap Biotech Stocks: Is it time to start trading?
It’s time to trade beaten-up small cap biotech stocks. 
Via Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower. 
Via Benzinga
Weekly Market Overview - Saturday, Jan. 29
Last week was a turbulent one for the stock market, with the S&P 500 declining about 100 points, or about 1.9% as of Thursday’s close. That might not sound like a lot, but the VIX reached its highest... 
Via Talk Markets
Top Picks 2022: Bristol-Myers Squibb (BMY)
Bristol-Myers Squibb is one of the world’s largest pharmaceutical companies. It manufactures cardiovascular and anti-cancer therapeutics, with annual revenues of about $42 billion. 
Via Talk Markets
Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Relapsed or Refractory DLBCL, PMBCL and FL3B
From Bristol Myers Squibb
Via Business Wire
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
42 43 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.